Reshma Kewalramani

Name: SmartMoneyDB 13F Holdings Database
License: https://www.sec.gov/privacy.htm#foia

CEO & President

Total Bought

Total Sold

$19.74M

Net Position

-$19.74M

Companies

Open-Market Trades

0 buys · 13 sells

Buy Hit Rate (90d)

—

Sell Timing (90d)

+100.00%

Weighted Return (90d)

+9.22%

Median: +8.68%

Active in:VRTX

Transaction History

Date	Company	Code	Type	Shares	Price	Value	30d	90d	180d
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	120	$481.50	$57.78K	+7.96%	+6.96%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	240	$482.84	$115.88K	+8.22%	+7.22%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	2,510	$487.13	$1.22M	+9.03%	+8.04%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	3,278	$488.27	$1.60M	+9.24%	+8.25%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	460	$489.32	$225.09K	+9.43%	+8.45%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	2,725	$490.54	$1.34M	+9.66%	+8.68%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	949	$491.30	$466.24K	+9.80%	+8.82%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	2,520	$493.29	$1.24M	+10.16%	+9.19%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	400	$479.75	$191.90K	+7.63%	+6.62%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	3,498	$494.33	$1.73M	+10.35%	+9.38%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	15,580	$495.38	$7.72M	+10.54%	+9.57%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	5,995	$496.16	$2.97M	+10.68%	+9.71%	—
Feb 27, 2026	VRTX VERTEX PHARMACEUTICALS INC / MA	S	Sale	1,725	$496.95	$857.24K	+10.82%	+9.86%	—